These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29960193)

  • 1. Prolonged therapy with antidepressants increases hippocampal level of kynurenic acid and expression of Kat1 and Kat2 genes.
    Kocki T; Urbańska EM; Kocki J; Kloc R; Kocka K; Olajossy M; Owe-Larsson B
    Pharmacol Rep; 2018 Aug; 70(4):737-745. PubMed ID: 29960193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.
    Kocki T; Wnuk S; Kloc R; Kocki J; Owe-Larsson B; Urbanska EM
    J Neural Transm (Vienna); 2012 Feb; 119(2):235-43. PubMed ID: 21660485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.
    Chmiel-Perzyńska I; Perzyński A; Olajossy B; Gil-Kulik P; Kocki J; Urbańska EM
    J Diabetes Res; 2019; 2019():4957879. PubMed ID: 31737685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats.
    Chmiel-Perzyńska I; Perzyński A; Urbańska EM
    Pharmacol Rep; 2014 Dec; 66(6):1134-9. PubMed ID: 25443746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.
    Zakrocka I; Turski WA; Kocki T
    Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure.
    Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J
    Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous level of kynurenic acid and activities of kynurenine aminotransferases following transient global ischemia in the gerbil hippocampus.
    Luchowska E; Luchowski P; Sarnowska A; Wielosz M; Turski WA; Urbańska EM
    Pol J Pharmacol; 2003; 55(3):443-7. PubMed ID: 14506324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
    Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
    Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family.
    Yu P; Li Z; Zhang L; Tagle DA; Cai T
    Gene; 2006 Jan; 365():111-8. PubMed ID: 16376499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats.
    Luchowski P; Luchowska E; Turski WA; Urbanska EM
    Neurosci Lett; 2002 Sep; 330(1):49-52. PubMed ID: 12213632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues.
    Yoshida Y; Fujigaki H; Kato K; Yamazaki K; Fujigaki S; Kunisawa K; Yamamoto Y; Mouri A; Oda A; Nabeshima T; Saito K
    Sci Rep; 2019 Jul; 9(1):10243. PubMed ID: 31308447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
    Kronsteiner C; Baran H; Kepplinger B
    Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
    Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
    J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental hypothyroidism raises brain kynurenic acid - Novel aspect of thyroid dysfunction.
    Tomczyk T; Urbańska EM
    Eur J Pharmacol; 2020 Sep; 883():173363. PubMed ID: 32663543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.